Hi RBx,
Are you able to ask Dr. Kelly why there was no interest in Veyonda from Novartis after the LUPIN trial which showed such great results ?
and him alluding on many occasions that there might be a commercial offer/arrangement coming from Novartis.
Professor Kelly comments..., page-3
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $5.326K | 50.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 418390 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 157540 | 6 |
View Market Depth
| Last trade - 15.15pm 27/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |